BIOLASE, Inc to Report Third Quarter 2021 Results on November 10, 2021
BIOLASE, Inc. (NASDAQ: BIOL) will release its third quarter 2021 financial and operating results on November 10, 2021, after U.S. financial markets close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BIOLASE, Inc. (NASDAQ: BIOL) will release its third quarter 2021 financial and operating results on November 10, 2021, after U.S. financial markets close. A conference call and webcast will be held at 4:30 p.m. ET to discuss the results and corporate developments. Participants can join via dial-in numbers: (800) 367-2403 for U.S./Canada and (334) 777-6978 internationally, using Conference ID 3599686. The live webcast and an audio archive will be available on the BIOLASE Investor Events Page.
Details
News Market Reaction – BIOL
The recorded move for BIOL in the trading session of this news was +8.92%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FOOTHILL RANCH, Calif., Nov. 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2021 financial and operating results on Wednesday, November 10, 2021 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.
For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is (800) 367-2403. For international participants outside the U.S./Canada, the dial-in number is (334) 777-6978. For all callers, refer to the Conference ID 3599686. To access the live webcast, go to BIOLASE Investor Events Page.
An audio archive of the webcast will also be available on the Investors section of the BIOLASE website.
About BIOLASE
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-inc-to-report-third-quarter-2021-results-on-november-10-2021-301415908.html
SOURCE BIOLASE, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.